Preventing tranfusion-transmitted infection is what Chiron is all about. As the world leader in blood safety for the transfusion industry, we develop novel tools, products and services to protect the global blood supply.

Chiron is the blood screening business of Novartis Vaccines and Diagnostics, a division of Novartis AG that was created in 2006 following the acquisition of Novartis Vaccines and Diagnostics.

Baxter International Inc. (NYSE:BAX) is a global healthcare company that, through its subsidiaries assists healthcare professionals and their patients with treatment of complex medical conditions including hemophilia, immune disorders, kidney disease, cancer, trauma and other conditions. With 2006 sales of $10.4 billion, and approximately 45,000 employees, Baxter applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.